Using the Chronic Kidney Disease Guidelines to Evaluate the Renal Safety of Tenofovir Disoproxil Fumarate in Hepatitis B Patients

Alimentary Pharmacology and Therapeutics- United Kingdom

doi 10.1111/apt.14682

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

April 25, 2018

Authors

Publisher

Wiley

Related search

Efficacy and Safety of Tenofovir Disoproxil Fumarate in Asian-Americans With Chronic Hepatitis B in Community Settings

Multidisciplinary

English

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Monotherapy With Tenofovir Disoproxil Fumarate for Multiple Drug-Resistant Chronic Hepatitis B: 3-Year Trial

English

Editorial: Tenofovir Disoproxil Fumarate and Prevention of Mother-To-Child Transmission of Hepatitis B Virus

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Lipid Profile and Renal Safety of Tenofovir Disoproxil Fumarate-Based Anti-Retroviral Therapy in HIV-infected Chinese Patients

International Journal of Infectious Diseases

Infectious Diseases

English

Exam 2: Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Renal Concerns in the Treatment of Chronic Hepatitis B With Tenofovir

Journal of Renal and Hepatic Disorders

English

Letter: Put on Your Thinking Cap - Tenofovir Disoproxil Fumarate for the Prevention of Vertical Transmission of Hepatitis B Virus

Alimentary Pharmacology and Therapeutics

Gastroenterology

English